FBCM
OACC

Fort Baker Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Fort Baker Capital Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Buy
1,105,394
+105,394
+11% +$1.12M 0.87% 36
2026
Q1 		$10.6M Buy
+1,000,000
New +$10.6M 0.83% 39

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Fort Baker Capital Management's OACC Position: Q2 2026 in Review

Fort Baker Capital Management increased its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 11% in Q2 2026, buying an estimated $1.12M and bringing the position to 1,105,394 shares worth $11.8M. The position accounts for 0.87% of the portfolio, ranked #36.

Fort Baker Capital Management first reported a position in OACC in Q1 2026 and has held it in 2 quarters since. 50 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Fort Baker Capital Management held 1,105,394 shares of Oaktree Acquisition Corp III Life Sciences worth $11.8M as of Q2 2026.
  • Fort Baker Capital Management bought 105,394 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $1.12M.
  • Oaktree Acquisition Corp III Life Sciences made up 0.87% of Fort Baker Capital Management's portfolio in Q2 2026, its #36 holding.
  • Fort Baker Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 50 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Fort Baker Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.